SEC, regulatory changes, compliance requirements.
JPMORGAN CHASE & CO’s finance-chief change puts succession on the clock. Filed on 2026-06-25; finance teams should review the record against disclosure controls, compliance calendars, board…
ILLUMINA, INC.’s finance-chief change puts succession on the clock. Filed on 2026-06-23; finance teams should review the record against disclosure controls, compliance calendars, board reporting…
IMA Tech’s auditor switch puts controls in focus. Filed on 2026-06-22; finance teams should review the record against disclosure controls, compliance calendars, board reporting, and legal-finance…
CINCINNATI FINANCIAL CORP’s finance-chief change puts succession on the clock. Filed on 2026-06-22; finance teams should review the record against disclosure controls, compliance calendars, board…
Grayscale HYPE ETF filed S-1/A on 2026-05-22; finance teams should review the record against disclosure controls, compliance calendars, board reporting, and legal-finance escalation.
Vivakor, Inc. filed S-1/A on 2026-05-22; finance teams should review the record against disclosure controls, compliance calendars, board reporting, and legal-finance escalation.
Alpha Compute Corp filed 424B3 on 2026-05-22; finance teams should review the record against disclosure controls, compliance calendars, board reporting, and legal-finance escalation.
REALLOYS INC. filed 8-K on 2026-05-22; finance teams should review the record against disclosure controls, compliance calendars, board reporting, and legal-finance escalation.
FS Credit Real Estate Income Trust, Inc. filed S-11/A on 2026-05-22; finance teams should review the record against disclosure controls, compliance calendars, board reporting, and legal-finance…
Ares Real Estate Income Trust Inc. filed 8-K on 2026-05-22; finance teams should review the record against disclosure controls, compliance calendars, board reporting, and legal-finance escalation.
Traws Pharma, Inc. filed 424B5 on 2026-05-22; finance teams should review the record against capital planning, dilution analysis, offering calendars, and public-market readiness.
AFLAC INC filed 424B2 on 2026-05-22; finance teams should review the record against disclosure controls, compliance calendars, board reporting, and legal-finance escalation.
Immix Biopharma, Inc. filed 424B5 on 2026-05-21; finance teams should review the record against disclosure controls, compliance calendars, board reporting, and legal-finance escalation.
TRACTOR SUPPLY CO /DE/ filed 8-K on 2026-05-21; finance teams should review the record against disclosure controls, compliance calendars, board reporting, and legal-finance escalation.
GATX CORP filed 8-K on 2026-05-21; finance teams should review the record against disclosure controls, compliance calendars, board reporting, and legal-finance escalation.